Daubers - Even if Leo has multiple potential partners and others interested in licenses.
Wouldn't all of that planning and pre-work have to WAIT until the Phase II trial is completed and AT LEAST 30 days for a review from the FDA to see and confirm the results.
Am I missing something here.
There's not even an approval from the FDA to proceed yet.
I don't see any big announcements for partners/licensing/deals occurring until around Jan./Feb time frame. Can anyone else line this up any better?
Looking forward to a higher PPS and more widespread news and recognition by industry leaders for our little Brilacidin "Covid Killer" in the coming weeks ahead.